MiMedx Group, Inc. announced it has secured a revolving line of credit with Bank of America. The revolving line of credit facility, which is secured by the company's accounts receivable and inventory, allows MiMedx to borrow up to $3.0 million through May 1, 2014. The facility will be used for general corporate purposes.
MiMedx is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.